SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms|Carcinoma, Non-Small-Cell Lung
Interventions: DRUG: SCH 727965|DRUG: Capecitabine|DRUG: Erlotinib
Sponsor: Merck Sharp & Dohme LLC